Hurjui Daniela Maria, Niţă Otilia, Graur Lidia Iuliana, Mihalache Laura, Popescu Dana Stefana, Huţanaşu I C, Ungureanu Didona, Graur Mariana
Clinical Center of Diabetes, Nutrition and Metabolic Diseases, University of Medicine and Pharmacy, Grigore T. Popa-Iaşi Sf. Spiridon Hospital, Iaşi.
Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):692-9.
To evaluate the prevalence of steatosis and to assess its correlations with the classical cardiovascular (CV) risk factors, components of metabolic syndrome (MS) in a rural population.
A sample of 254 subjects was enrolled in the study. Collected data included: age, gender, complete medical history, anthropometric and blood pressure (BP) measurements. The biological evaluation included metabolic and hepatic parameters. Ultrasound evaluation of steatosis relied on the criteria of the National Health and Nutrition Examination Survey (NHANES) III.
Two thirds of the study population were obese or overweight (64.96%); 32.66% had systolic BP and 27.16% diastolic BP levels higher than normal. 38% of the subjects had abnormal fasting blood glucose levels, 14.56% having glycated hemoglobin (HbA1c) values corresponding to pre-diabetes, and 9.84% to overt diabetes; 8% had low HDL-cholesterol and 14.96% high triglycerides (Tg) levels. MS was present in 50.8% of individuals. Only 10.8% of all subjects did not have an ultrasound appearance of steatosis; 28.8% had moderate and 32% severe steatosis. There were statistically significant differences in subjects with steatosis vs. subjects without steatosis with regard to body mass index (BMI), WC, presence of MS, and BP and Tg levels, but not to ALAT, ASAT and GGT values.
The important prevalence of obesity, fasting hyperglycamia, steatosis and MS shows a particularly metabolic fragile population; early diagnosis and interventional strategies are mandatory.
评估农村人群中脂肪变性的患病率,并评估其与经典心血管(CV)危险因素、代谢综合征(MS)各组分之间的相关性。
本研究纳入了254名受试者。收集的数据包括:年龄、性别、完整病史、人体测量数据和血压(BP)测量值。生物学评估包括代谢和肝脏参数。脂肪变性的超声评估依据美国国家健康与营养检查调查(NHANES)III的标准。
三分之二的研究人群肥胖或超重(64.96%);32.66%的受试者收缩压和27.16%的受试者舒张压高于正常水平。38%的受试者空腹血糖水平异常,14.56%的糖化血红蛋白(HbA1c)值处于糖尿病前期,9.84%处于显性糖尿病状态;8%的受试者高密度脂蛋白胆固醇水平低,14.96%的受试者甘油三酯(Tg)水平高。50.8%的个体存在MS。所有受试者中只有10.8%没有脂肪变性的超声表现;28.8%为中度脂肪变性,32%为重度脂肪变性。在体重指数(BMI)、腰围(WC)、MS的存在、血压和Tg水平方面,有脂肪变性的受试者与无脂肪变性的受试者之间存在统计学显著差异,但谷丙转氨酶(ALAT)、谷草转氨酶(ASAT)和γ-谷氨酰转肽酶(GGT)值无差异。
肥胖、空腹血糖升高、脂肪变性和MS的高患病率表明该人群代谢特别脆弱;早期诊断和干预策略必不可少。